Top 20 of Hypertension, Renal

Article title # Publications/# Citations

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

2007: HKobori; MNangaku; LGNavar; ANishiyama;

205

Chronic kidney disease: effects on the cardiovascular system.

2007: MLLipman; JFMann; ELSchiffrin;

125

Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

1977: DWCushman; MAOndetti; BRubin;

100

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

2003: UKPDS Group; AIAdler; RWBilous; CACull; RRHolman; SEManley; RJStevens;

94

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

2001: KLGordon; JHughes; JAJefferson; RJJohnson; DHKang; YGKim; SKivlighn; HYLan; MMazzali;

94

NADPH oxidases in the kidney.

2006 Sep-Oct: PSGill; CSWilcox;

83

Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

2004: BDHammock; JDImig; IHKim; JWNewman; DMPollock; JSPollock; JStewart; TWatanabe; TYamamoto; XZhao;

76

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

1985: SAnderson; BMBrenner; TWMeyer; HGRennke;

74

Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

1972: TGColeman; AVCowley; ACGuyton; RDManning; RANorman; KWScheel;

69

Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.

2002: LMHarrison-Bernard; HKobori; LGNavar;

69

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

1986: SAnderson; BMBrenner; HGRennke;

67

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

1986: SAnderson; BMBrenner; BRDunn; TWMeyer; HGRennke; RZatz;

66

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

1999: GGarini; GGherardi; APerna; GRemuzzi; PRuggenenti; MSalvadori; FPSchena; FScolari; CZoccali;

66

Letter: Nomogram for Bayes theorem.

1975: TJFagan;

62

Racial differences in the incidence of treatment for end-stage renal disease.

1982: KAKirk; BAPate; SGRostand; EARutsky;

61

CLINICAL AND RADIOLOGICAL FEATURES OF URINARY INFECTION IN CHILDHOOD.

1964: DEdwards; CJHodson; ICNormand; JMSmellie;

60

Glomerular number and size in autopsy kidneys: the relationship to birth weight.

2003: JFBertram; RDouglas-Denton; ABFarris; WEHoy; MHughson;

58

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

1972: LBaer; HRBrunner; FRBuhler; JHLaragh; EDVaughan;

56

Circulation: overall regulation.

1972: TGColeman; HJGranger; ACGuyton;

54

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

1982: BMBrenner; THHostetter; HGRennke;

54